Michael H. Gelb

From Wikipedia, the free encyclopedia

Professor Michael H. Gelb is a biochemist specialising in enzymes and particularly those of medical significance.

Gelb studied chemistry and biochemistry at the University of California, Davis before taking a Ph.D under Stephen G. Sligar at Yale University on aspects of the catalytic mechanism of cytochrome P450. Granted an American Cancer Society postdoctoral fellowship, he then investigated mechanism-based inactivators of serine proteases and developed fluorinated ketones as tight-binding inhibitors of several classes of proteases, working with Robert H. Abeles at Brandeis University.

Since 1985 Gelb has been a faculty member at the University of Washington.

Gelb's awards include:

The Pfizer Award in Enzyme Chemistry.
The ICI Pharmaceuticals Award for Excellence in Chemistry (1993).
An Afred P. Sloan Fellowship.
A New Faculty Development Award from Merck Research Laboratories.

His current research interests include serving on the Structural Genomics of Pathogenic Protozoa (SGPP) team, which will determine the x-ray crystal structures of malaria and trypanosomatid proteins as part of an NIH funded center.

In his spare time Gelb enjoys surfing and playing classical guitar.